Lymphangiogenic VEGF-C and VEGFR-3 expression in genetically characterised gastrointestinal stromal tumours

Histol Histopathol. 2011 Dec;26(12):1499-507. doi: 10.14670/HH-26.1499.

Abstract

This study aimed to assess the distribution of VEGF-C and VEGFR-3 expression in gastrointestinal stromal tumours (GISTs), and to analyse the value of lymphatic vessel density (LVD) in a tumour that is believed to preferentially metastasize through blood vessel conduits. A panel of immunohistochemical antibodies was used to evaluate 51 cases of genetically characterised GISTs: VEGF-C, VEGFR-3, D2-40 (for LVD assessment) and CD31 (for blood vessel density--BDV--assessment). The results were correlated with the clinical-pathological data. The large majority of cases (86.2%; 44/51) showed a mutation of the KIT gene, most of them (72.5%; 37/51) revealing mutations in exon 11. VEGFR-3 was predominantly expressed in KIT mutated GISTs (p=0.019). High LVD was correlated with the absence of metastasis (p=0.010) and high BVD showed a positive correlation with the occurrence of metastasis (p=0.049). The strong expression of VEGF-C and VEGFR-3 in GIST's cells was not correlated with the clinical parameters of aggressiveness, nor with high LVD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived
  • Biomarkers, Tumor / analysis*
  • Blood Vessels / chemistry
  • Brazil
  • DNA Mutational Analysis
  • Female
  • Gastrointestinal Stromal Tumors / blood supply
  • Gastrointestinal Stromal Tumors / chemistry*
  • Gastrointestinal Stromal Tumors / genetics
  • Gastrointestinal Stromal Tumors / mortality
  • Gastrointestinal Stromal Tumors / pathology
  • Humans
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Lymphangiogenesis*
  • Lymphatic Vessels / chemistry*
  • Lymphatic Vessels / pathology
  • Male
  • Middle Aged
  • Mutation
  • Neoplasm Invasiveness
  • Platelet Endothelial Cell Adhesion Molecule-1 / analysis
  • Predictive Value of Tests
  • Prognosis
  • Proto-Oncogene Proteins B-raf / genetics
  • Proto-Oncogene Proteins c-kit / genetics
  • Receptor, Platelet-Derived Growth Factor alpha / genetics
  • Retrospective Studies
  • Survival Rate
  • Time Factors
  • Vascular Endothelial Growth Factor C / analysis*
  • Vascular Endothelial Growth Factor Receptor-3 / analysis*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Biomarkers, Tumor
  • Platelet Endothelial Cell Adhesion Molecule-1
  • VEGFC protein, human
  • Vascular Endothelial Growth Factor C
  • monoclonal antibody D2-40
  • Proto-Oncogene Proteins c-kit
  • Receptor, Platelet-Derived Growth Factor alpha
  • Vascular Endothelial Growth Factor Receptor-3
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf